Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Akanda | AKAN | Nov 15, 2024 | 1.39 | -6.08 |
Akari Therapeutics ADR | AKTX | Nov 15, 2024 | 2.08 | -6.73 |
Akebia Therapeutics | AKBA | Nov 15, 2024 | 1.79 | -3.76 |
Akero Therapeutics | AKRO | Nov 15, 2024 | 28.09 | -5.61 |
Akoustis Technologies | AKTS | Nov 15, 2024 | 0.06 | +18.69 |
Akoya BioSciences | AKYA | Nov 15, 2024 | 2.41 | -23.00 |
Akso Health ADR | AHG | Nov 15, 2024 | 0.95 | -20.17 |
Alamo Group | ALG | Nov 15, 2024 | 194.31 | +0.67 |
Alamos Gold | AGI | Nov 15, 2024 | 17.54 | -1.13 |
Alarm.com | ALRM | Nov 15, 2024 | 59.85 | -0.13 |
Alarum Technologies ADR | ALAR | Nov 15, 2024 | 14.27 | +2.37 |
Alaska Air Group | ALK | Nov 15, 2024 | 53.96 | +2.04 |
Alaunos Therapeutics | TCRT | Nov 15, 2024 | 2.09 | -10.59 |
Albany International | AIN | Nov 15, 2024 | 80.09 | -0.53 |
Albemarle | ALB | Nov 15, 2024 | 103.53 | +1.40 |
Albemarle ADR A Pref | ALB-A | Nov 15, 2024 | 47.39 | -0.69 |
Albertsons Companies A | ACI | Nov 15, 2024 | 18.88 | -1.15 |
Alchemy Investments Acquisition 1 | ALCY | Nov 15, 2024 | 12.25 | +8.79 |
Alchemy Investments Acquisition 1 Units | ALCYU | Nov 15, 2024 | 12.10 | +0.75 |
Alcoa | AA | Nov 15, 2024 | 44.02 | +6.82 |
Alcon | ALC | Nov 15, 2024 | 85.13 | -0.05 |
Aldel Financial II | ALDFU | Nov 15, 2024 | 10.00 | 0.00 |
Aldeyra Therapeutics | ALDX | Nov 15, 2024 | 4.21 | -1.41 |
Alector | ALEC | Nov 15, 2024 | 4.07 | -17.21 |
Alerian Energy Infrastructure E | ENFR | Nov 15, 2024 | 31.36 | +0.77 |
Alerus Financial | ALRS | Nov 15, 2024 | 22.09 | -0.27 |
Alexander & Baldwin | ALEX | Nov 15, 2024 | 19.30 | +1.15 |
Alexanders | ALX | Nov 15, 2024 | 217.15 | -0.27 |
Alexandria Real Estate Equities | ARE | Nov 15, 2024 | 105.58 | -2.48 |
Algoma Steel Group | ASTL | Nov 15, 2024 | 10.84 | +0.18 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.